
SALADINI FRANCESCO
Contacts
0577235077 [int.5077]
Teaching activities
Completion accademic year: 2025/2026
Completion accademic year: 2024/2025
Completion accademic year: 2023/2024
Completion accademic year: 2022/2023
Completion accademic year: 2021/2022
Completion accademic year: 2020/2021
Completion accademic year: 2019/2020
Research
Ultime pubblicazioni:
- Giammarino, F., Paletti, C., Bartolini, N., Fiaschi, L., Biba, C., Varasi, I., et al. (2025). Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro. ANTIVIRAL RESEARCH, 239 [10.1016/j.antiviral.2025.106157]. - view more
- Armenia, D., Carioti, L., Micheli, V., Bon, I., Allice, T., Bonura, C., et al. (2024). Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy. VIRUSES, 16(9) [10.3390/v16091422]. - view more
- Giammarino, F., de Salazar, A., Malet, I., Vinuela, L., Fuentes, A., Saladini, F., et al. (2024). Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes. THE JOURNAL OF INFECTIOUS DISEASES, 229(6), 1796-1802 [10.1093/infdis/jiae010]. - view more
- Fiaschi, L., Biba, C., Varasi, I., Bartolini, N., Paletti, C., Giammarino, F., et al. (2024). In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants. VIRUSES, 16(2), 1-12 [10.3390/v16020168]. - view more
- Panza, F., Saladini, F., Bartolini, N., Gianmarino, F., Montagnani, F., Spagnuolo, V., et al. (2024). PRESTIGIO RING “a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests”. NEW MICROBIOLOGICA, 47(1), 116-122. - view more